To study the correlation of serum lactate dehydrogenase (LDH) levels in women with preeclampsia on maternal and perinatal outcome
Introduction: Pre-eclampsia is a multi-system disorder of unknown etiology and a major cause of maternaland perinatal complications. LDH is an intracellular enzyme and is increased when there isincreased cell death. As pre-eclampsia leads to cellular death, so LDH levels can beusedtoassesstheseverityofdisease. Aim: To study the correlation of levels of serum LDH in women with preeclampsia on maternal and perinatal outcome.
Objectives: To correlate the maternal and perinatal outcomes with serum LDH levels. To assess serum LDH as a marker for severity of preeclampsia.
Materials and Methods: A prospective comparative studywas conducted over a period of 18 months from November 2016 to April 2018 in the department of Obstetrics and Gynecology, Sri Siddhartha Medical Hospital, Tumakuru. Out of 180 women studied, 100 were normal pregnant women, 40 patients were having mild preeclampsia and 40 patients were having severe preeclampsia. The two groups and subgroups were studied based on age, gravidity, trimester, investigations, maternal and perinatal outcome, complications and follow up.
Results: Higher values of LDH were found in mild and severe preeclamptic women than those of normal pregnant women in third trimester and was statistically significant. Severe lypreec lamptic patients had increased LDH levels which in association with investigations, outcome, complications and follow up was significant.
Conclusion: LDH is a useful biochemical marker and can be considered as a supportive prognostic tool thatreflects the severity and complications of preeclampsia. Identification of high-risk patients, theirclose monitoring, and correct management may prevent these complications.
2. Gabbe SG, Niebyl JR, Simpson JL, Landon MB, Galan HL, Jauniaux ERM, Driscoll DA, Berghella V, Grobman WA. Obstetrics Normal and Problem Pregnancies. 7th ed. China. Elsevier; 2017: 662-703.
3. Hak J, Un-Nisa N, Gupta S. LDH Levels in Pregnancy and its Association with Severity of the Disease and Feto-maternal Outcome in Pre-eclampsia and Eclampsia. Jk science. 2015; 17(3): 110-13.
4. Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013; 1(4): 365-68.
5. Thamilkothai R, Bhavanidevi V, Ramalakhsmi S. Role of Serum Lactate Dehydrogenase As A Prognostic Biochemical Marker in Pre-Eclampsia And Eclampsia. Ind J Res. 2016; 5(5): 187-88.
6. Andrews L et al. Maternal outcome in relation to Biochemical parameters in Hypertensive disorders in Pregnancy. IOSR-JDMS. 2014; 13(2): 18-22.
7. Behera NR, Patel J. Maternal outcome in antepartum eclampsia caesarean versus vaginal delivery. Int J Reprod Contracept Obstet Gynecol. 2018; 7(4): 1330-35.
8. Talwar P, Kondareddy T, Pranidha CA. LDH as a prognostic marker in hypertensive pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017; 6(6): 2444-46.
9. Mary VP, Chellatamizh M, Padmanaban S. Role of serum LDH in preeclampsia as a prognostic factor – a cross sectional case control study in tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2017; 6(2): 595-98.
10. Jain R, Upadhyay C, Mehta L, Nayak B, Desai G. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia, Gujarat. Int J ReprodContracept Obstet Gynecol. 2017; 6(8): 3418-22.
11. Gopinath S, Shafi M, Ramegowda HK, Mehta PK. Outcome of referred obstetric emergencies at a tertiary centre. Int J Biol Med Res. 2016; 7(2): 5518-21.
12. Umasatyasri Y, Vani I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia-eclampsia as a prognostic marker: An observational study. IAIM. 2015; 2(9): 88-93.
13. Rajoria L, Nenkar S, Gidwani C. Lactic acid dehydrogenase and uric acid as prognostic markers for hypertensive disorders of pregnancy. IJSAR. 2018; 5(2): 12-17.
14. Dave A, Maru L, Jain A. LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia. J ObstetGynaecol India. 2016 Feb;66(1):23-9. doi: 10.1007/s13224-014-0645-x. Epub 2014 Dec 2.[pubmed]
15. Bhave NV, Shah PK. A correlation of lactate dehydrogenase enzyme levels in pregnancy induced hypertensive disorders with severity of disease, maternal and perinatal outcome. Int J Reprod Contracept Obstet Gynecol. 2017; 6(10): 4302-08.
16. Gupta G. A case control study to evaluate correlation of anaemia with severe preeclampsia. Int J Reprod Contracept Obstet Gynecol. 2018; 7(7): 2773-77.
17. Kant RH, Mir N, Sarwar S, Gupta S, Najeeb R. Role of maternal serum lactate dehydrogenase as a biochemical marker in preeclampsia. IOSR Journal of Dental And Medical Sciences. 2005; 14(7): 12-19.
18. Qublan HS et al. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia. Med Sci Monit, 2005; 11(8): 393-97.[pubmed]
19. Singh P, Gaikwad HS, Marwah S, Mittal P, Kaur C. Role Of Serum Lactate Dehydrogenase In Pregnancy Induced Hypertension With Its Adverse Feto-Maternal Outcome- A Case-Control Study. Journal Of Clinical And Diagnostic Research. 2018; 12(5): 19-23.
20. Catanzarite VA, Steinberg SM, Mosley CA, et al. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death. Am J Perinatol. 1995 Sep;12(5):310-3.[pubmed]
21. Ciryam SS, Gomathy E. Study of serum lactate dehydrogenase level and seasonal variation in preeclampsia and eclampsia with its obstetric outcome. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8): 3533-36.
22. Malarewics A, Gruszka O, Szymkiewicz J, Rogale J. The usefulness of routine laboratory tests in the evaluation of sudden threat of pregnant women and fetus in preeclampsia. Ginecol Pol. 2006; 77(4): 276-84.
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.